1. Baird, TA, Parsons, MW, Phan, T, et al. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003; 34: 2208–2214.
Google Scholar | Crossref | Medline | ISI2. Capes, SE, Hunt, D, Malmberg, K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426–2432.
Google Scholar | Crossref | Medline | ISI3. Kazui, S, Minematsu, K, Yamamoto, H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28: 2370–2375.
Google Scholar | Crossref | Medline | ISI4. Kimura, K, Iguchi, Y, Inoue, T, et al. Hyperglycemia independently increases the risk of early death in acute spontaneous intracerebral hemorrhage. J Neurol Sci 2007; 255: 90–4.
Google Scholar | Crossref | Medline5. Piironen, K, Putaala, J, Rosso, C, et al. Glucose and acute stroke. Stroke 2012; 43: 898–902.
Google Scholar | Crossref | Medline | ISI6. Tsivgoulis, G, Katsanos, AH, Mavridis, D, et al. Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score-matched analysis from the SITS-ISTR registry. Diabetes 2019; 68: 1861–1869.
Google Scholar | Crossref | Medline7. Bellolio, MF, Gilmore, RM, Ganti, L. Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev 2014: Cd005346.
Google Scholar | Crossref | Medline8. Johnston, KC, Bruno, A, Pauls, Q, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE Randomized Clinical Trial. JAMA 2019; 322: 326–335.
Google Scholar | Crossref | Medline9. Ntaios, G, Egli, M, Faouzi, M, et al. J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 2010; 41: 2366–2370.
Google Scholar | Crossref | Medline | ISI10. Monnier, L, Colette, C, Owens, DR. Glycemic variability: the third component of the dysglycemia in diabetes. J Diabetes Sci Technol 2008; 2: 1094–1100.
Google Scholar | SAGE Journals11. Krinsley, JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008–3013.
Google Scholar | Crossref | Medline | ISI12. Hermanides, J, Vriesendorp, TM, Bosman, RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med 2010; 38: 838–842.
Google Scholar | Crossref | Medline | ISI13. Camara-Lemarroy, C. Glucose and stroke: what about glycemic variability? J Neurologic Sci 2017; 373: 242–243.
Google Scholar | Crossref | Medline14. Gonzalez-Moreno, EI, Camara-Lemarroy, CR, Gonzalez-Gonzalez, JG, et al. Glycemic variability and acute ischemic stroke: the missing link. Transl Stroke Res 2014; 5: 638–646.
Google Scholar | Crossref | Medline15. Hui, J, Zhang, J, Mao, X, et al. The initial glycemic variability is associated with early neurological deterioration in diabetic patients with acute ischemic stroke. Neurol Sci 2018; 39: 1571–1577.
Google Scholar | Crossref | Medline16. Kim, JT, Lee, SY, Yoo, DS, et al. Clinical implications of serial glucose measurements in acute ischemic stroke patients treated with intravenous thrombolysis. Sci Rep 2018; 8: 11761.
Google Scholar | Crossref | Medline17. Kim, YS, Kim, C, Jung, KH, et al. Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke. PLoS ONE 2017; 12: e0183894.
Google Scholar18. Lim, JS, Kim, C, Oh, MS, et al. Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments. J Diabetes Complications 2018; 32: 682–687.
Google Scholar | Crossref | Medline19. Shimoyama, T, Kimura, K, Uemura, J, et al. Post stroke dysglycemia and acute infarct volume growth: a study using continuous glucose monitoring. Eur Neurol 2016; 76: 167–174.
Google Scholar | Crossref | Medline20. Wada, S, Yoshimura, S, Inoue, M, et al. Outcome prediction in acute stroke patients by continuous glucose monitoring. J Am Heart Assoc 2018; 7: e008744.
Google Scholar | Crossref21. Yoon, JE, Sunwoo, JS, Kim, JS, et al. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients. J Diabetes Complications 2017; 31: 390–394.
Google Scholar | Crossref | Medline22. Palaiodimou, L, Lioutas, VA, Lambadiari, V, et al. Glycemia management in acute ischemic stroke: current concepts and novel therapeutic targets. Postgrad Med 2019; 131: 423–437.
Google Scholar | Crossref | Medline23. Powers, WJ, Rabinstein, AA, Ackerson, T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344–e418.
Google Scholar | Crossref | Medline24. Hemphill, JC, Greenberg, SM, Anderson, CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 2015; 46: 2032–2060.
Google Scholar | Crossref | Medline | ISI25. Steiner, T, Al-Shahi Salman, R, Beer, R, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014; 9: 840–855.
Google Scholar | SAGE Journals | ISI26. Tsivgoulis, G, Lioutas, VA, Varelas, P, et al. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Neurology 2017; 89: 1142–1151.
Google Scholar | Crossref | Medline27. Liantinioti, C, Palaiodimou, L, Tympas, K, et al. Potential utility of neurosonology in paroxysmal atrial fibrillation detection in patients with cryptogenic stroke. J Clin Med 2019; 8: 2002.
Google Scholar | Crossref | Medline28. Roussopoulou, A, Tsivgoulis, G, Krogias, C, et al. Safety of urgent endarterectomy in acute non-disabling stroke patients with symptomatic carotid artery stenosis: an international multicenter study. Eur J Neurol 2019; 26: 673–679.
Google Scholar | Crossref | Medline29. Safouris, A, Krogias, C, Sharma, VK, et al. Statin pretreatment and microembolic signals in large artery atherosclerosis. Arterioscler Thromb Vasc Biol 2017; 37: 1415–1422.
Google Scholar | Crossref | Medline30. Adams, HP, Bendixen, BH, Kappelle, LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35–41.
Google Scholar | Crossref | Medline | ISI31. Meretoja, A, Strbian, D, Putaala, J, et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 2012; 43: 2592–2597.
Google Scholar | Crossref | Medline | ISI32. Kothari, RU, Brott, T, Broderick, JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27: 1304–1305.
Google Scholar | Crossref | Medline | ISI33. Health NIo . National Institute of Neurological Disorders and Stroke. Stroke Scale, https://www.ninds.nih.gov/sites/default/files/NIH_Stroke_Scale_Booklet.pdf
Google Scholar34. Seners, P, Turc, G, Oppenheim, C, et al. Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications. J Neurol Neurosurg Psychiatry 2015; 86: 87–94.
Google Scholar | Crossref | Medline | ISI35. Tsivgoulis, G, Goyal, N, Iftikhar, S, et al. Sulfonylurea pretreatment and in-hospital use does not impact acute ischemic strokes (AIS) outcomes following intravenous thrombolysis. J Stroke Cerebrovasc Dis 2017; 26: 795–800.
Google Scholar | Crossref | Medline36. van Swieten, JC, Koudstaal, PJ, Visser, MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–607.
Google Scholar | Crossref | Medline | ISI37. Fuentes, B, Ntaios, G, Putaala, J, et al. European Stroke Organisation (ESO) guidelines on glycaemia management in acute stroke. Eur Stroke J 2018; 3: 5–21.
Google Scholar | SAGE Journals | ISI38. 15. Diabetes Care in the Hospital: standards of medical care in diabetes—2019 . Diabetes Care 2019; 42(Suppl. 1): S173–S81.
Google Scholar39. Hill, NR, Oliver, NS, Choudhary, P, et al. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011; 13: 921–928.
Google Scholar | Crossref | Medline | ISI40. Kovatchev, BP, Cox, DJ, Kumar, A, et al. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 2003; 5: 817–828.
Google Scholar | Crossref | Medline41. Ryan, EA, Shandro, T, Green, K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955–962.
Google Scholar | Crossref | Medline | ISI42. Molnar, GD, Taylor, WF, Ho, MM. Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 1972; 8: 342–348.
Google Scholar | Crossref | Medline | ISI43. Kovatchev, BP, Otto, E, Cox, D, et al. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006; 29: 2433–2438.
Google Scholar | Crossref | Medline | ISI44. Wójcicki, JM. ‘J’-index. A new proposition of the assessment of current glucose control in diabetic patients. Hormone Metab Res 1995; 27: 41–42.
Google Scholar | Crossref | Medline | ISI45. Service, FJ, Molnar, GD, Rosevear, JW, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644–655.
Google Scholar | Crossref | Medline | ISI46. Hill, NR, Hindmarsh, PC, Stevens, RJ, et al. A method for assessing quality of control from glucose profiles. Diabet Med 2007; 24: 753–758.
Google Scholar | Crossref | Medline | ISI47. SCHLICHTKRULL, J, MUNCK, O, JERSILD, M. The M-valve, an index of blood-sugar control in diabetics. Acta Med Scand 1965; 177: 95–102.
Google Scholar | Crossref | Medline48. McDonnell, CM, Donath, SM, Vidmar, SI, et al. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005; 7: 253–263.